12/30/2025Suzhou Launches China’s First Nuclear Medicine Demonstration Base

12/30/2025Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China’s ...

12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China

12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China

12/30/2025Novo Nordisk Cuts Price of Wegovy in China Ahead of Patent Expiry

12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801

12/30/2025Adlai Nortye Grants ASK Pharma Exclusive Rights for Pan-RAS Inhibitor ...

12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...

12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China

12/30/2025China Approves AstraZeneca and Ionis' Wainua for ATTRv-PN

12/30/2025AstraZeneca's Fasenra Approved for EGPA in China

12/30/2025Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecific ADC SIM0610 i...

12/30/2025Innovent Submits Clinical Trial Application for Novel Bispecific Dual-...

12/27/2025Telix Advances Regulatory Efforts with Positive China Phase 3 Data

12/27/2025CDE Seeks Comments on Chinese Translation of ICH M8 eCTD Guidelines

12/27/2025NMPA Announces Adoption of ICH E6(R3) Guidelines for Clinical Trial Qu...

12/27/2025Hemacell Completes Series B1 Financing to Advance Platelet Regeneratio...

12/27/2025Chengdu Maxvax Biotech Completes D+ Financing Round

12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...

12/27/2025LyncBio Therapeutics Completes Strategic Pre-A Financing Round

12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia

12/27/2025Frontera's HKSE IPO Application Accepted

12/27/2025GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval

12/27/2025Guangzhou Novaken Pharm Files for HKSE Main Board Listing

12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis

12/27/2025Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...

12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...

12/27/2025Coherent Licenses CBP-1018 to MultiValent Biotherapies in Major Global...

12/23/2025Aurobindo Pharma to Increase Stake in Chinese JV Luoxin Aurovitas

12/23/2025CSPC Announces China Approval for Daratumumab Injection

Page:1/58 Total number of articles:1735: [First][<<] [1] [2] [3] [4] [5] [>>] [End]